Development of Spontaneous Subdural Hematoma and Bone Marrow Depression after Hydroxyethyl Starch Administration

Journal of Pediatrics

Volumn 153, Issue 4, 2008, Pages

  Chappell, Daniel ^a   Bruchelt, Waltraud ^a   Schenk, Wilfried ^b   Jacob, Matthias ^a   Hofmann Kiefer, Klaus ^a   Conzen, Peter ^a   Kreimeier, Uwe ^a   Rehm, Markus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b KLINIKUM AUGSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; CEFOTAXIME; CORTISONE; DEXAMETHASONE; DEXAMISOLE; DIPHENHYDRAMINE; HETASTARCH; PENTOXIFYLLINE; VON WILLEBRAND FACTOR;

ARTICLE; BONE MARROW DEPRESSION; CASE REPORT; CLINICAL FEATURE; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; HEMOPHILIA A; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; SUBDURAL HEMATOMA;

EID: 51449096948     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.04.073     Document Type: Article

References (18)

1. Kozek-Langenecker S.A. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 103 (2005) 654-660
2. Michel O., Jahns T., Joost-Enneking M., Neugebauer P., Streppel M., and Stennert E. The Stennert antiphlogistic-rheologic infusion schema in treatment of cochleovestibular disorders. HNO 48 (2000) 182-188
3. Bork K. Pruritis precipitated by hydroxyethyl starch: a review. Br J Dermatol 152 (2005) 3-12
4. de Jonge E., and Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 29 (2001) 1261-1267
5. Mittermayr M., Streif W., Haas T., Fries D., Velik-Salchner C., Klingler A., et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 105 (2007) 905-917
6. de Jonge E., Levi M., Buller H.R., Berends F., and Kesecioglu J. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects. Intensive Care Med 27 (2001) 1825-1829
7. Jones S.B., Whitten C.W., Despotis G.J., and Monk T.G. The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. Anesth Analg 96 (2003) 363-368
8. Sadler J.E., Budde U., Eikenboom J.C., Favaloro E.J., Hill F.G., Holmberg L., et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor. J Thromb Haemost 4 (2006) 2103-2114
9. Nitu-Whalley I.C., and Lee C.A. Acquired von Willebrand syndrome-report of 10 cases and review of the literature. Haemophilia 5 (1999) 318-326
10. Barron M.E., Wilkes M.M., and Navickis R.J. A systematic review of the comparative safety of colloids. Arch Surg 139 (2004) 552-563
11. Boon J.C., Jesch F., Ring J., and Messmer K. Intravascular persistence of hydroxyethyl starch in man. Eur Surg Res 8 (1976) 497-503
12. Rehm M., Haller M., Orth V., Kreimeier U., Jacob M., Dressel H., et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology 95 (2001) 849-856
13. Aly H.A., Lochbuehler H., Frey L., and Messmer K. Global tissue oxygenation during normovolaemic haemodilution in young children. Paediatr Anaesth 7 (1997) 197-204
14. Jungheinrich C., and Neff T.A. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 44 (2005) 681-699
15. Treib J., Haass A., Pindur G., Seyfert U.T., Treib W., Grauer M.T., et al. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorrheology, coagulation and elimination kinetics. Thromb Haemost 74 (1995) 1452-1456
16. Jonville-Bera A.P., Utret-Leca E., and Gruel Y. Acquired type I von Willebrand's disease associated with highly substituted hydroxyethyl starch. N Engl J Med 345 (2001) 622-623
17. Sirtl C., Laubenthal H., Zumtobel V., Kraft D., and Jurecka W. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth 82 (1999) 510-515
18. Christidis C., Mal F., Ramos J., Senejoux A., Callard P., Navarro R., et al. Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions. J Hepatol 35 (2001) 726-732